Literature DB >> 2566576

The levels of zeta, gamma, and delta chains in patients with Hb H disease.

F Kutlar1, J M Gonzalez-Redondo, A Kutlar, A Gurgey, C Altay, G D Efremov, K Kleman, T H Huisman.   

Abstract

Details are given of a study of blood samples from 24 patients with Hb H disease from different Mediterranean countries and from the Far East. Four different types of alpha-thal-1 (--) were observed, namely -(alpha) (approximately 20.5-kb deletion); --MED-I (approximately 17.5-kb deletion); --MED-II (greater than 26.5-kb deletion); and --SEA (approximately 18-kb deletion, in Orientals only). The alpha-thal-2 was mainly of the deletion type (16 with the 3.7-kb deletion; 1 with the 4.2-kb deletion), while 4 of the 7 patients with a nondeletional type had the five-nucleotide deletion at the donor splice site of the first intron of the alpha 2 gene. All patients had a mild-to-moderate hemolytic anemia; no significant differences in hematology were observed between the groups. Hb A2 was decreased to about one-third of the normal level. The Hb H formation varied considerably and its quantitation was not always satisfactory. Patients with Hb H disease due to any alpha-thal-1 combined with a nondeletional alpha-thal-2 had the highest Hb H levels and a more marked anemia. The zeta chain production was small and absent in patients with the MED-II type of alpha-thal-1 because this deletion included the zeta and psi zeta genes. The highest zeta chain levels were present in the four patients with the SEA type of alpha-thal-1. The gamma chain production was increased, particularly in patients with a mutation of C----T at position -158 to the G gamma globin gene. This gamma chain was primarily present as Hb Bart's (or gamma 4) and only about 15% was recovered as Hb F or alpha 2 gamma 2. The evaluation of the rate of gamma chains produced in these patients was greatly facilitated by data from one patient who had Hb H disease and a heterozygosity for the A gamma-beta+-HPFH. The low levels of Hb A2 and of Hb F (relative to Hb Bart's) can be explained by a decreased affinity of alpha chains for delta and gamma chains as compared with beta chains in conditions of severe alpha chain deficiency.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2566576     DOI: 10.1007/BF00284054

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  32 in total

1.  Estimation of small percentages of foetal haemoglobin.

Authors:  K BETKE; H R MARTI; I SCHLICHT
Journal:  Nature       Date:  1959-12-12       Impact factor: 49.962

2.  Hematological observations on Arabian SS patients with a homozygosity or heterozygosity for a beta S chromosome with haplotype #31.

Authors:  A Kutlar; Y Hattori; I Bakioglu; F Kutlar; K Kamel; T H Huisman
Journal:  Hemoglobin       Date:  1985       Impact factor: 0.849

3.  Alpha-thalassemia haplotypes in the Algerian population.

Authors:  T Henni; F Morlé; B Lopez; P Colonna; J Godet
Journal:  Hum Genet       Date:  1987-03       Impact factor: 4.132

4.  Recombination at the human alpha-globin gene cluster: sequence features and topological constraints.

Authors:  R D Nicholls; N Fischel-Ghodsian; D R Higgs
Journal:  Cell       Date:  1987-05-08       Impact factor: 41.582

5.  Alpha zero-thalassemia due to recombination between the alpha 1-globin gene and an AluI repeat.

Authors:  R D Nicholls; D R Higgs; J B Clegg; D J Weatherall
Journal:  Blood       Date:  1985-06       Impact factor: 22.113

6.  Five adults with mild sickle cell anemia share a beta S chromosome with the same haplotype.

Authors:  I Bakioglu; Y Hattori; A Kutlar; C Mathew; T H Huisman
Journal:  Am J Hematol       Date:  1985-11       Impact factor: 10.047

7.  The rare alpha-thalassemia-1 of blacks is a zeta alpha-thalassemia-1 associated with deletion of all alpha- and zeta-globin genes.

Authors:  A E Felice; M P Cleek; K McKie; V McKie; T H Huisman
Journal:  Blood       Date:  1984-05       Impact factor: 22.113

8.  Gene deletions in alpha thalassemia prove that the 5' zeta locus is functional.

Authors:  L Pressley; D R Higgs; J B Clegg; D J Weatherall
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

9.  Clinical and genetic heterogeneity in black patients with homozygous beta-thalassemia from the southeastern United States.

Authors:  J M Gonzalez-Redondo; T A Stoming; K D Lanclos; Y C Gu; A Kutlar; F Kutlar; T Nakatsuji; B Deng; I S Han; V C McKie
Journal:  Blood       Date:  1988-09       Impact factor: 22.113

10.  Haplotypes of beta S chromosomes among patients with sickle cell anemia from Georgia.

Authors:  Y Hattori; F Kutlar; A Kutlar; V C McKie; T H Huisman
Journal:  Hemoglobin       Date:  1986       Impact factor: 0.849

View more
  6 in total

1.  A monoclonal antibody-linked immunoassay for hemoglobin H disease.

Authors:  M Shyamala; C R Kiefer; H Moscoso; F A Garver
Journal:  Ann Hematol       Date:  1992-07       Impact factor: 3.673

2.  A rare case of coinheritance of Hemoglobin H disease and sickle cell trait combined with severe iron deficiency.

Authors:  Michael Medinger; Elisabeth Saller; Cornelis L Harteveld; Thomas Lehmann; Lukas Graf; Alicia Rovo; Andreas Buser; Jakob Passweg; André Tichelli
Journal:  Hematol Rep       Date:  2011-12-06

3.  The Hematological and Molecular Spectrum of α-Thalassemias in Turkey: The Hacettepe Experience.

Authors:  Şule Ünal; Fatma Gümrük
Journal:  Turk J Haematol       Date:  2015-06       Impact factor: 1.831

4.  Hemoglobin H Disease in Turkey: Experience from Eight Centers.

Authors:  Selma Ünal; Gönül Oktay; Can Acıpayam; Gül İlhan; Edip Gali; Tiraje Celkan; Ali Bay; Barış Malbora; Nejat Akar; Yeşim Oymak; Tayfur Toptaş
Journal:  Turk J Haematol       Date:  2015-08-06       Impact factor: 1.831

5.  A combination of the -α3.7 and --MEDII alleles causing hemoglobin H disease in a Brazilian patient.

Authors:  Roberta Dorta Ferreira; Natália de Oliveira Mota; Elza Myiuki Kimura; Gisele Audrei Pedroso; Maria de Fatima Sonati
Journal:  Rev Bras Hematol Hemoter       Date:  2016-12-28

6.  Breakpoint characterization of a rare alpha0 -thalassemia deletion using targeted locus amplification on genomic DNA.

Authors:  Quint P Hottentot; Emile de Meijer; Henk P J Buermans; Stefan J White; Cornelis L Harteveld
Journal:  Int J Lab Hematol       Date:  2021-07-12       Impact factor: 3.450

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.